Terumo

Compare

5 Followers

4543 Stock Chart & Stats

¥2554.50

¥11.00(0.37%)

At close: Jan 08 4:00 PM EST

¥2554.50

¥11.00(0.37%)

Day’s Range― - ―

52-Week Range¥2,352.00 - ¥3,182.00

Previous CloseN/A

Volume2.29M

Average Volume (3M)4.22M

Market Cap

¥3.67T

Enterprise Value¥3.88T

Total Cash (Recent Filing)¥204.29B

Total Debt (Recent Filing)¥169.85B

Price to Earnings (P/E)30.3

Beta0.72

Next Earnings

Nov 12, 2025

EPS Estimate

24.5

Last Dividend Ex-Date

Sep 29, 2025

Dividend Yield1.13%

Share Statistics

EPS (TTM)28.37

Shares Outstanding1,480,559,700

10 Day Avg. Volume3,337,480

30 Day Avg. Volume4,218,923

Financial Highlights & Ratios

PEG Ratio3.37

Price to Book (P/B)3.03

Price to Sales (P/S)4.00

P/FCF Ratio29.12

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥3,399.94

Price Target Upside33.10% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Innovation RecognitionTerumo has been recognized for its innovative needle technology, making it a top choice for pharmaceutical packaging of popular GLP-1 weight loss drugs.

Market ExpansionThe joint venture with Weigao Blood Purification allows Terumo to tap into China's large market, potentially increasing its market presence.

Product AdvancementTerumo is following the market movement from predominantly glass-focused syringes to polymeric materials, bringing along multiple benefits including higher break resistance and less risk of reaction with drugs.

Bears Say

Growth OpportunitiesThe delay in the IPO of Weigao Blood Purification on the HKEX could be detrimental to Terumo, as the listing could boost growth.

Market ExpansionThe delay in the IPO of Weigao Blood Purification could be detrimental to Terumo, as the listing could boost growth.

Pricing PressureThere is a risk of price cuts for hemodialysis systems in China due to the country's Volume Based Procurement scheme.

Terumo News

Terumo Corporation Revises Shareholder Benefit Program to Boost Engagement

Terumo ( ($JP:4543) ) has issued an update. Terumo Corporation announced an amendment to its Shareholder Benefit Program,...

2M ago

Terumo Acquires OrganOx to Enter Organ Transplantation Sector

Terumo ( ($JP:4543) ) just unveiled an update. Terumo Corporation has announced its acquisition of OrganOx Limited for...

2M ago

Terumo Corporation Reports Modest Revenue Growth

Terumo ( ($TRUMF) ) has released its Q1 earnings. Here is a breakdown of the information Terumo presented...

3M ago

Terumo’s Earnings Call: Record Revenue Amid Challenges

Terumo (($JP:4543)) has held its Q1 earnings call. Read on for the main highlights of the call. During...

3M ago

Terumo Corporation Reports Increased Profits and Dividend Guidance

Terumo ( ($JP:4543) ) just unveiled an update. Terumo Corporation reported a modest increase in revenue for the...

3M ago

Terumo (TRUMF) Q1 Earnings Cheat Sheet

Terumo (TRUMF) is scheduled to report 1st quarter earnings on 08/07/2025, before the market opens. Regarding Q1 estimates,...

3M ago

Terumo Finalizes Stock Options Issuance Details

Terumo ( ($JP:4543) ) just unveiled an update. Terumo Corporation has finalized the details regarding the issuance of...

3M ago

Terumo Completes Disposal of Treasury Shares for Stock Remuneration

An announcement from Terumo ( ($JP:4543) ) is now available. Terumo Corporation has completed the disposal of 101,606...

3M ago

Terumo Corporation Issues Stock Options to Enhance Executive Alignment

An update from Terumo ( ($JP:4543) ) is now available. Terumo Corporation announced the issuance of stock options...

4M ago

Terumo Corporation Announces Disposal of Treasury Shares as Restricted Stock Remuneration

Terumo ( ($JP:4543) ) has provided an announcement. Terumo Corporation announced its decision to dispose of 101,606 treasury...

4M ago

4543 FAQ

What was Terumo’s price range in the past 12 months?

Terumo lowest stock price was ¥2352.00 and its highest was ¥3182.00 in the past 12 months.

What is Terumo’s market cap?

Terumo’s market cap is ¥3.67T.

When is Terumo’s upcoming earnings report date?

Terumo’s upcoming earnings report date is Nov 12, 2025 which is in 12 days.

How were Terumo’s earnings last quarter?

Terumo released its earnings results on Aug 07, 2025. The company reported ¥28.37 earnings per share for the quarter, beating the consensus estimate of ¥24.399 by ¥3.971.

Is Terumo overvalued?

According to Wall Street analysts Terumo’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Terumo pay dividends?

Terumo pays a Semiannually dividend of ¥15 which represents an annual dividend yield of 1.13%. See more information on Terumo dividends here

What is Terumo’s EPS estimate?

Terumo’s EPS estimate is 24.5.

How many shares outstanding does Terumo have?

Terumo has 1,480,559,700 shares outstanding.

What happened to Terumo’s price movement after its last earnings report?

Terumo reported an EPS of ¥28.37 in its last earnings report, beating expectations of ¥24.399. Following the earnings report the stock price went down -1.21%.

Which hedge fund is a major shareholder of Terumo?

Currently, no hedge funds are holding shares in JP:4543

Company Description

Terumo

Terumo Corporation (4543) is a global medical technology company based in Japan, specializing in a wide range of healthcare products and services. The company operates primarily in two sectors: Medical Devices and Blood Management. Terumo's core offerings include vascular access devices, transfusion systems, and interventional cardiology products. The company is committed to advancing medical technology and improving patient outcomes through innovative solutions.

Terumo (4543) Earnings & Revenues

Historic Earnings Reports

4543 Company Deck

4543 Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflects a predominantly positive outlook with record-high revenue, strong operating profit growth, and effective pricing strategies. However, challenges such as decreased free cash flow, temporary revenue declines in specific segments, and potential future impacts from tariffs were noted.View all JP:4543 earnings summaries

4543 Stock 12 Month Forecast

Average Price Target

¥3,399.94

▲(33.10% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2303":"¥2,303","3102":"¥3,102","3901":"¥3,901","2702.5":"¥2,702.5","3501.5":"¥3,501.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3900.2440513361,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥3.90K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3399.9389872617,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥3.40K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2899.6339231873,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.90K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2303,2702.5,3102,3501.5,3901],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"May<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2666.556,2761.455080872008,2856.3541617440155,2951.2532426160233,3046.1523234880306,3141.0514043600383,3235.950485232046,3330.849566104054,3425.7486469760615,3520.647727848069,3615.546808720077,3710.4458895920843,3805.344970464092,{"y":3900.2440513361,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2666.556,2722.9700759432076,2779.3841518864156,2835.798227829623,2892.2123037728306,2948.626379716038,3005.040455659246,3061.4545316024537,3117.8686075456617,3174.282683488869,3230.6967594320768,3287.1108353752843,3343.5249113184923,{"y":3399.9389872617,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2666.556,2684.485071014408,2702.4141420288156,2720.343213043223,2738.2722840576307,2756.2013550720385,2774.1304260864463,2792.0594971008536,2809.9885681152614,2827.917639129669,2845.846710144077,2863.7757811584843,2881.704852172892,{"y":2899.6339231873,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2304.671,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2617.938,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2508.652,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2644.521,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2633.691,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2697.854,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2855.649,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2899.179,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2752.526,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2761.471,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2586.053,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2547.789,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2666.556,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >